Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation
© Brodarac et al.; licensee BioMed Central. 2015
Received: 22 May 2014
Accepted: 19 March 2015
Published: 23 April 2015
Induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) may be suitable for myocardial repair. While their functional and structural properties have been extensively investigated, their response to ischemia-like conditions has not yet been clearly defined.
iPS-CMs were differentiated and enriched from murine induced pluripotent stem cells expressing enhanced green fluorescent protein (eGFP) and puromycin resistance genes under the control of an α-myosin heavy chain (α-MHC) promoter. iPS-CMs maturity and function were characterized by microscopy, real-time PCR, calcium transient recordings, electrophysiology, and mitochondrial function assays, and compared to those from neonatal murine cardiomyocytes. iPS-CMs as well as neonatal murine cardiomyocytes were exposed for 3 hours to hypoxia (1% O2) and glucose/serum deprivation, and viability, apoptosis markers, reactive oxygen species, mitochondrial membrane potential and intracellular stress signaling cascades were investigated. Then, the iPS-CMs response to mesenchymal stromal cell-conditioned medium was determined.
iPS-CMs displayed key morphological and functional properties that were comparable to those of neonatal cardiomyocytes, but several parameters indicated an earlier iPS-CMs maturation stage. During hypoxia and glucose/serum deprivation, iPS-CMs exhibited a significantly higher proportion of poly-caspase-active, 7-aminoactinomycin D-positive and TUNEL-positive cells than neonatal cardiomyocytes. The average mitochondrial membrane potential was reduced in “ischemic” iPS-CMs but remained unchanged in neonatal cardiomyocytes; reactive oxygen species production was only increased in “ischemic” iPS-CMs, and oxidoreductase activity in iPS-CMs dropped more rapidly than in neonatal cardiomyocytes. In iPS-CMs, hypoxia and glucose/serum deprivation led to upregulation of Hsp70 transcripts and decreased STAT3 phosphorylation and total PKCε protein expression. Treatment with mesenchymal stromal cell-conditioned medium preserved oxidoreductase activity and restored pSTAT3 and PKCε levels.
iPS-CMs appear to be particularly sensitive to hypoxia and nutrient deprivation. Counteracting the ischemic susceptibility of iPS-CMs with mesenchymal stromal cell-conditioned medium may help enhance their survival and efficacy in cell-based approaches for myocardial repair.
Transplantation of cardiomyocytes (CMs) into injured myocardium has been shown to improve contractile function in animal models of heart disease [1,2]. With advances in genetic reprogramming technology, creation of induced pluripotent stem cells (iPSCs) and improvements in differentiation protocols, it is now possible to produce large quantities of patient-specific, autologous CMs (induced pluripotent stem cell-derived cardiomyocytes; iPS-CMs) in vitro [3,4]. However, low retention, survival, and engraftment of transplanted CMs in the ischemic heart greatly hamper clinical application of these cells . Cell loss is dramatic even when cell types with high tolerance to ischemia, such as mesenchymal stromal cells (MSCs), are transplanted into infarcted myocardium . A detailed understanding of the cellular response to ischemia-like stress is therefore necessary for improving the efficacy of cell-based myocardial regeneration. Structurally and functionally, iPS-CMs were shown to display properties of fetal or neonatal CMs [7-10]. In contrast to adult mature CMs, which depend on oxidative metabolism for ATP synthesis, immature CMs can generate ATP through glycolysis and should to be more resistant to hypoxia [11,12]. We therefore analyzed the response of murine iPS-CMs and their neonatal murine counterparts (N-CMs) to hypoxia and glucose/serum deprivation (GSD) in vitro, and also tested the potential of paracrine factors secreted from bone marrow-derived multipotent MSCs to protect iPS-CMs from deleterious effects of “simulated in vitro ischemia” [13,14].
Induced pluripotent stem cell differentiation and purification
Neonatal mouse cardiomyocytes
N-CMs were purchased from ScienceCell (Provitro, Berlin, Germany), where they were characterized by immunostaining with antibodies specific to smooth muscle actin, sarcomeric alpha-actinin, and tropomyosin. Their purity was estimated to be between 95 and 97%, with viability approximately 98%. N-CMs were cultured in medium that selectively promotes CM growth to preserve their purity and prevent outgrowth by non-CMs. It consisted of basal medium (cat. no.6201), 5% FBS (cat. no. 0025), 1% of specific CM growth supplement (cat. no. 6252) and 1% of penicillin/streptomycin solution (cat. no. 0503) (all from Provitro). At confluency, after 10 to 12 days in culture, cells were trypsinized and 40,000 cells/well plated on fibronectin-coated plates for subsequent analyses.
On differentiation day 21, cells were fixed with 4% buffered paraformaldehyde (PFA) and permeabilized with 0.1% Triton X-100. Followed by blocking in 5% goat serum, cells were stained with anti-sarcomeric-α-actinin (clone EA-53, 1:400; Sigma, Sigma-Aldrich, Steinheim, Germany) in 0.8% bovine serum albumin/phosphate-buffered saline (BSA/PBS). After washing in PBS, incubation with anti-mouse-igG1 Alexa Fluor 555 was performed (1:500;) in 0.8% BSA/PBS (Sigma-Aldrich, Steinheim, Germany) for 60 minutes at room temperature and nuclei were stained with 2 μg/ml Hoechst 33342 (Life Technologies). Images were acquired using the high content screening (HCS) imaging system Operetta® and Harmony® software (PerkinElmer, Waltham, MA, USA).
Cells were fixed by immersion with 3 to 6% (v/v) glutaraldehyde in 0.1 M sodium cacodylate buffer, rinsed twice for 15 minutes in 0.1 M cacodylate buffer, pH 7.2, post-fixed for 120 minutes with 1% OsO4 in 0.1 M cacodylate buffer, pH 7.2, at room temperature in the dark, rinsed again, dehydrated with acetone and embedded in araldite CY212 (Durcupan ACM, Fluka, Sigma, St.Louis, MO, USA). Ultrathin sections were cut at grey interference colour (25 to 30 nm) with a 35°-diamond knife (Diatome, Hatfield, PA, USA) on an Ultracut E (Leica, Buffalo Grove, IL, USA), mounted on formvar/carbon-coated copper grids and contrasted with uranyl acetate and lead citrate. Microscopy was performed with a Zeiss EM109 (80 kV, 500 μm condenser 1 aperture, 200 μm condenser 2 aperture, 30um objective aperture; Carl Zeis Jena, Germany) equipped with a temperature-stabilized wide angle YAC-CCD camera at the side entry port (1024 × 1024 pixel, 12-bit greyscale/pixel; firstname.lastname@example.org). Magnification was calibrated with a cross grating replica (2,160 lines/mm, d = 0.463 μm).
Recording of intracellular calcium transients
iPS-CMs cultured in chamber slides were loaded with 2 μM Fura 2-AM (Molecular Probes, Life Technologies, Carlsbad, CA, USA) in Hank’s balanced salts modified buffer (HBSS, pH 7.4) for 15 minutes at 37°C, and washed twice for 15 minutes in HBSS. The slides were placed on a temperature-regulated microscope stage and kept at 37°C. Fluorescence images were acquired using the IonWizard Transient Analysis software package (IonOptix Limited, Dublin, Ireland) together with an Olympus IX70 inverted fluorescence microscope (40× Fura-UV objective) (Myocyte Calcium & Contractility Recording System; Ion Optix Limited). The data shown represent the average of Fura-2 ratio (R340/380) for 35 iPS-CMs from three independent experiments.
Determination of oxygen consumption rate
For oxygen consumption rate (OCR) quantification, 20,000 iPS-CMs were seeded into each well of a Seahorse XFe96 cell culture plate and cultured for 2 days to ensure firm adherence to the cell culture plate. On the day of measurement, the medium was changed to pre-warmed Seahorse Assay medium and OCR determined according to the manufacturer’s instructions using the Seahorse XF Cell Mito Stress Kit (all from Seahorse Bioscience, North Billerica, MA, USA). Basal respiration was measured in unstimulated cells during three cycles of measurement. Afterwards, oligomycin (1 μM) was added to quantify ATP production followed by carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP; 1 μM) injection to assess maximal cellular respiration (respiratory capacity). Finally, antimycin A and rotenone (1 μM) treatment revealed the amount of non-mitochondrial respiration.
iPS-CMs and N-CMs aggregates were dispersed using collagenase B  or trypsin/EDTA, respectively, followed by addition of neutralization solution (all Provitro). Single cells were incubated at 37°C in DMEM/20% metal calf serum (FCS) for 24 to 36 hours before measurements were performed. Action potentials (APs) of spontaneously beating CMs were measured by means of the whole-cell current clamp technique using an EPC-9 amplifier and the PULSE software package (Heka Elektronik, Lambrecht, Germany). The experiments were performed at 37°C in standard extracellular solution containing (in mMol/l) 140 NaCl, 5.4 KCl, 1.8 CaCl2, 1 MgCl2, 10 HEPES and 10 glucose, or 136 NaCl, 5.4 KCl, 0.33 NaH2PO4, 1 MgCl2, 10 glucose, 5 HEPES and 1.8 CaCl2 (pH 7.4, adjusted with NaOH). Patch-clamp pipettes, prepared from glass capillary tubes (Harvard Apparatus Ltd, Kent, UK) with a two-stage horizontal puller (DMZ Universal Puller, Munich, Germany), had a resistance of 2 to 3 MΩ when filled with intracellular solution containing (in mMol/l) 50 KCl, 80 KAspartate, 1 MgCl2, 3 MgATP, 10 EGTA and 10 HEPES (pH 7.4).
Isoproterenol and carbachol (Sigma-Aldrich, Steinheim, Germany) were prepared freshly before the experiments and applied using gravitational flow. Data were analyzed off-line with custom-made analysis software (kindly provided by Prof. Philipp Sasse, University of Bonn, Germany).
Exposure of cells to hypoxia and glucose/serum deprivation
Puromycin-selected iPSC-derived cardiac clusters were dissociated at day 16 of differentiation with 0.25% trypsin-EDTA and plated on a 2.5 μg/ml fibronectin-coated 96-well plate at the density of 40,000 cells/well in high-glucose DMEM, supplemented with 15% FBS, 1% non-essential amino acids, and 50 μM β-mercaptoethanol (all from Life Technologies). Puromycin (8 μg/ml) was maintained in culture medium and refreshed every second day to prevent the outgrowth of any proliferating cells that may contaminate purified CM preparations. Five days after plating and culture in a humidified incubator (CB 210; Binder, Tuttlingen, Germany) at 37°C, 5% CO2 and atmospheric oxygen concentration (21%), parallel plates were transferred to an incubator (CB 150; Binder) maintained at 1% O2 and incubated for 3, 5 or 7 hours in: a) basal DMEM, high glucose supplemented with both 10% FBS and glucose; b) DMEM, no glucose containing only 10% FBS; c) DMEM, high glucose containing only glucose; or d) DMEM, no glucose lacking both serum and glucose. Control cells were kept for equivalent time periods under normoxic standard conditions. After establishing the conditions leading to reproducibly detectable cell damage, all subsequent experiments were performed by incubating iPS-CMs and N-CMs for 3 hours in hypoxia (1% O2) in glucose- and serum-deprived medium as summarized in Figure 1A. The analyses of various cell viability parameters were performed at the end of the hypoxia period, without reoxygenation. The number and density of iPS-CMs and N-CMs incubated under control conditions was similar as determined by cell counting at the end of the incubation period, using the Operetta® HCS.
For detection of cells undergoing apoptosis, iPS-CMs and N-CMs were plated in 96-well ViewPlates (PerkinElmer). Poly-caspase-active cells were visualized using the fluorescent poly-caspase reagent, R-VAD-FMK (SR-FLICA; Biomol, Hamburg, Germany), a sensitive and early detector of apoptosis initiation. Following incubation under control conditions or hypoxia and/or GSD, medium was aspirated, 60 μl/well of SR-FLICA reagent was added, and cells were incubated for the next 45 minutes at 21% O2. Cells were washed with Dulbecco’s PBS, fixed with 4% PFA, and nuclei were stained with 2 μg/ml Hoechst 33342 (Life Technologies). Finally, cells were visualized and quantitatively analyzed using the Operetta® HCS. In addition, the activity of caspase-3/7, -8 and -9 was assessed using specific substrates reconstituted in respective caspase-Glo-3/7, -8 or -9 buffer (Promega, Mannheim, Germany). Following incubation in hypoxia/GSD and control conditions, 60 μl of reagent was added to an equal volume of medium in 96-well transparent plates (Greiner Bio-One, Frickenhausen, Germany), and incubated for 1 hour at room temperature; 100 μl from each well was then transferred to opaque 96-well plates and luminescence, directly proportional to the amount of caspase activity, was recorded using a Mithras LB 940 Multimode Microplate Reader (Berthold Technologies, Bad Wildbad, Germany).
7-aminoactinomycin D staining
Late apoptotic and necrotic cells were detected using 7-aminoactinomycin D (7-AAD) (Biomol). 7-AAD was reconstituted in 260 μl DMSO and diluted 1:250 in DMEM (high glucose) supplemented with 10% FBS. Following incubation in hypoxia or control conditions, 60 μl of reagent was added to cells, which were then incubated for 15 minutes at room temperature. Cells were fixed with 4% PFA and nuclei stained with Hoechst 33342. Quantitation of 7-AAD-positive cells was performed using the Operetta® HCS.
DNA fragmentation was detected using the in situ cell death detection kit (Roche, Mannheim, Germany). Cells were fixed with 4% PFA for 60 minutes at room temperature and permeabilized with 0.25% Triton X-100. After washing in PBS, reagent was added for 60 minutes at 37°C followed by Hoechst 33342 staining. Cells were visualized and quantitatively analyzed using the Operetta® HCS.
Mitochondrial membrane integrity
Analysis of the mitochondrial membrane potential was performed in control cells and cells subjected to hypoxia/GSD using the JC-1 Mitochondrial Membrane Potential Probe (Life Technologies). JC-1 was added into medium at 2 μM final concentration for 30 minutes incubation at room temperature. Then, cells were fixed with 4% PFA and nuclei stained with Hoechst 33342. The loss of “granulated” JC-1 staining in CMs and conversion into a homogenous staining pattern indicated breakdown of the mitochondrial membrane potential . Quantification was performed using the Operetta® HCS.
Mitochondrial transmembrane potential
The mitochondrial transmembrane potential was measured using the tetramethylrhodamine methyl ester (TMRM) fluorescence method (Life Technologies). TMRM dye was added to the medium at 125 nM final concentration for 30 minutes incubation at 37°C, followed by 3 minutes incubation with Hoechst 33342. The loss of mitochondrial membrane potential causes TMRM to leak from mitochondria, resulting in a loss of fluorescence intensity. Live images of cells were recorded for TMRM fluorescence and quantitation of fluorescence intensity was performed using the Operetta® HCS.
Reactive oxygen species measurement
Oxidative stress induced by reactive oxygen species (ROS) was measured using CellROX® Deep Red Reagent (Life Technologies). CellROX® reagent was added at a final concentration of 5 μM to the cells and incubated for 30 minutes at 37°C. After washing in PBS, cells were fixed with 4% PFA and nuclei stained with Hoechst 33342. Images were acquired and quantification of the fluorescence signal was performed using the Operetta® HCS.
Metabolic activity was analyzed using the colorimetric CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay (Promega), based on the reduction of tetrazolium dye MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to its insoluble formazan by NADPH-dependent oxidoreductases. Following 3 hours incubation (40,000 CMs/well) in 1% O2 in hypoxia/GSD or control conditions, 70 μl of the MTS/PMS solution was added at 50 μl medium/well and incubated for 4 hours at 21% O2. Absorbance was measured at 490 nm directly in the 96-well plate using a SpectraMax Plus384 Absorbance Microplate Reader (Molecular Devices, Sunnyvale, CA, USA). The number of cells/well was counted using the Operetta® HCS, and was confirmed to be similar between experimental groups. Blank values from wells without cells were subtracted.
Cardiomyocyte ATP content was analyzed using the CellTiter-Glo Luminescent Cell Viability Assay (Promega). Briefly, 60 μl reagent (CellTiter-Glo buffer/substrate) was added (1:1) to 40,000 CMs/well cultured in 96-well plates following incubation in hypoxia/GSD or control conditions, and the plate was placed on an orbital shaker at room temperature for 2 minutes (200 rpm). The content of the plate was left to equilibrate for an additional 10 minutes at room temperature, before 100 μl from each well were transferred to opaque 96-well plates and luminescence was recorded using a Mithras LB 940 Multimode Microplate Reader (Berthold Technologies). The number of cells/well was counted using the Operetta® HCS and was confirmed to be similar between experimental groups. Blank values from cell-free wells filled with medium and CellTiter-Glo buffer/substrate were substracted.
Preparation of mesenchymal stromal cell-conditioned medium and fibroblast-conditioned medium
Bone marrow-derived MSCs were isolated from 8-week-old C57BL/6 mice and characterized as previously described . The local Animal Ethics Committee (Deutsches Herzzentrum and Charite-Universitätsmedizin Berlin) granted approval, and all procedures conformed to the guidelines from Directive 2010/63/EU of the European Parliament. Fibroblasts were isolated from CF-1 mouse strain at E13.5-E14.5 according to standard protocols. Fibroblasts and MSCs were grown until 80 to 90% confluence in IMDM medium (PAN Biotech, Aidenbach, Germany) supplemented with 5% FBS and 2.5 ng/ml recombinant human basic fibroblast growth factor (Peprotech, Hamburg, Germany) in 21% O2. For the collection of conditioned medium, cells were washed thoroughly twice with Dulbecco's PBS and cultured in serum/glucose-deprived medium at 1% O2 for 72 hours. After 72 hours, conditioned medium was collected and centrifuged for 5 minutes at 300 x g at room temperature. Equivalent medium kept under the same conditions in culture flasks without cells was used as a control. Cell viability after 72 hours exposure to hypoxia/GSD was evaluated by Trypan blue exclusion.
To determine the effect of MSC-conditioned medium (MSC-CoM) and fibroblast-conditioned medium (FB-CoM) on the viability of iPS-CMs exposed to hypoxia and nutrient deprivation, iPS-CMs and N-CMs cells maintained under baseline conditions (DMEM in 15% FBS and glucose, 21% O2) were washed twice with Dulbecco's PBS, and standard culture medium was replaced with DMEM without FBS and without glucose or with MSC-CoM/FB-CoM (60 μl/well in a 96-well plate) for 3 hours incubation at 1% O2. Cell viability parameters were analyzed immediately after the experiment.
RNA extraction, cDNA synthesis and real-time PCR
Primers used for real-time quantitative PCR
Primer sequence (5′→3′)
Annealing temperature (°C)
Murine iPS-CMs cells were lysed in SDS lysis buffer supplemented with complete proteinase inhibitor cocktail and PhosSTOP phosphatase inhibitor cocktail tablets (Roche Diagnostics, Mannheim, Germany). Protein concentration was determined by BCA protein assay (Thermo Scientific, Bonn, Germany). Aliquots containing equal amounts of proteins (20 to 30 μg) were resolved by 10% SDS-PAGE and transferred onto nitrocellulose membranes (Karl Roth, Karlsruhe, Germany). Membranes were blocked and incubated with monoclonal mouse anti-total-protein and rabbit anti-phospho-protein primary antibodies overnight at 4°C: PKCε (1:500, cat. no. sc-214, Santa Cruz Biotechnology, Dallas, Texas, USA), Akt (1:2000, cat. no. 2920, Cell Signaling, Danvers, Massachusetts, USA), phospho-Akt (Ser473, 1:2000, cat. no. 4060, Cell Signaling), STAT3 (1:1000, cat. no. 9139, Cell Signaling), and phospho-STAT3 (Tyr705, 1:2000, cat. no. 9145, Cell Signaling). GAPDH served as a loading control (1:1000, cat. no. 2118, Cell signaling). After 1 hour incubation with IRDye® conjugated secondary antibodies (Li-Cor Bioscience, Bad Homburg, Germany), blots were analyzed using the infrared imaging system and software Odyssey® from Li-Cor Bioscience and quantified by ImageJ software.
For every analysis, at least three independent experiments were performed, each done in triplicate. Data are presented as mean value ± SEM. Data from two independent groups of samples were compared using Student’s t test. Three or more groups of samples were compared using one-way analysis of variance with Bonferroni post-hoc analysis. A P value ≤0.05 was considered statistically significant. Tests were carried out using IBM SPSS Statistics 20 software (IBM, Armonk, NY, USA).
Induced pluripotent stem cell-derived cardiomyocyte differentiation
Spontaneously beating, GFP-positive areas in EBs were first observed on days 8 to 9 of differentiation (Figure 1B). After puromycin selection, the remaining cell clusters were composed exclusively of GFP-positive cells, which represented more than 95% of all viable cells as determined by flow cytometry of enzymatically dissociated clusters at day 16 (Figure 1C). When these cells were plated and cultured for an additional 5 days on fibronectin-coated plates in the presence of puromycin, they all stained positive for cardiac sarcomeric protein α-actinin (Figure 1D).
Induced pluripotent stem cell-derived cardiomyocyte phenotype and function
Induced pluripotent stem cell-derived cardiomyocyte hypoxia and glucose/serum deprivation in vitro model
Neonatal cardiomyocyte and induced pluripotent stem cell-derived cardiomyocyte response to hypoxia and glucose/serum deprivation
There were distinct differences between iPS-CMs and N-CMs regarding the preservation of metabolic activity in hypoxia/GSD. Cytosolic and mitochondrial oxidoreductase activity was reduced by 67 ± 3.3% in iPS-CMs, but did not change in N-CMs after 3 hours hypoxia/GSD (−0.014 ± 1.8%; P < 0.001; Figure 8A). We therefore followed oxidoreductase activity for longer periods of hypoxia GSD and found that it dropped by 73 ± 0.5% in iPS-CMs and by 20 ± 6.5% in N-CMs after 5 hours (P < 0.001), and by 77 ± 2% in iPS-CMs and 42 ± 3.1% in N-CMs after 7 hours (P < 0.001), confirming a higher sensitivity to hypoxia/GSD of iPS-CMs throughout the experimental protocols (Figure 8A). Furthermore, we assessed cytoplasmic ATP levels, which were similar in iPS-CMs and N-CMs in normoxic control conditions (Figure 8B). During 3 hours hypoxia/GSD, however, cytoplasmic ATP decreased by 83 ± 0.9% in iPS-CMs and by 61 ± 0.4% in N-CMs (P < 0.001).
Cytoprotective effect of mesenchymal stromal cell-conditioned medium
Signaling response of induced pluripotent stem cell-derived cardiomyocytes to mesenchymal stromal cell-conditioned medium
So far, somatic stem cell therapy for heart repair has yielded disappointing clinical results , mainly because the capacity of non-pluripotent progenitors to re-create contractile cells upon transplantation in the failing heart has been overestimated. In this context, induced pluripotent stem cell technology offers the possibility to create large numbers of syngeneic CMs for potential clinical transplantation in the failing heart. Although there are concerns regarding the genetic stability of reprogrammed cells and their progeny [22,23], there are currently few, if any, conceptually sound alternatives for re-generation of contractile myocardium. iPS-CMs where previously shown to possess all the baseline phenotypic and functional characteristics of both CMs derived from embryonic stem cells and those isolated from neonatal myocardium [8-10,24,25], but little is known about their behavior in a hostile environment as it is encountered in a diseased heart.
We found that exposure to hypoxia combined with GSD,as a model of “simulated in vitro ischemia” led within 3 hours to caspase activation in almost 50% of the iPS-CMs, associated with an increased proportion of necrotic and TUNEL-positive cells, breakdown of the mitochondrial membrane potential in one third of the cells, increased accumulation of ROS, and a reduction of the average oxidoreductase activity by more than 60%. These findings mirror a substantial cell damage and are in line with studies showing that dying cells display characteristics of apoptosis, autophagy and necrosis at the same time . Overall, N-CMs appeared to be less sensitive to these conditions because they exhibited less caspase activation, a minimal increase in the percentage of necrotic, TUNEL-positive cells and ROS expression, preserved mitochondrial membrane potential and a delayed and less pronounced loss of oxidoreductase activity. In line with these findings, caspase-8, which is an essential component of the extrinsic cell death pathways, was activated only in iPS-CMs but not in murine N-CMs after 3 hours hypoxia/GSD. Chao and colleagues showed that rat N-CMs activated caspase-8 after 4 hours exposure to hypoxia and serum deprivation , so that our finding of a 3-hour period of relative resistance to hypoxia/GSD in murine N-CMs appears realistic. On the other hand, caspase-9 activity did not increase and caspase-3 activity was reduced in both iPS-CMs and N-CMs. The initiator caspase-9 is a key component of the mitochondrial death pathway and would be expected to play an even greater role in cell death secondary to hypoxia/GSD [18,28,29]. This intrinsic apoptosis-initiating pathway is typically initiated by opening of the mitochondrial permeability pore when oxidative metabolism breaks down, with the latter being confirmed by our findings regarding the mitochondrial membrane potential. However, apoptosis in “ischemia-like” situations may also occur independently of the intrinsic pathway in a process involving “extrinsic” caspase-8 activation. For instance, Schamberger and colleagues demonstrated that in rat embryonic cells caspase-8 seemed to be sufficient to initiate the serum starvation-induced apoptosis while the caspase-9 activation was impaired by sequestration of caspase-9 to cytoskeletal structures . Our finding of downregulated effector caspase-3/7 activity in both iPS-CMs and N-CMs underscores the relatively early stage of apoptosis induction in the majority of the cells or the non-apoptotic functions that these caspases may exert under these conditions, as has been described for several other cellular systems [31-33].
The key question is whether the increased susceptibility to hypoxia/GSD compared to N-CMs is a phenomenon caused by reprogramming, or reflects differences in CM maturity. As Keung and colleagues have recently summarized , controlling iPS-CM maturation is exceedingly important in order to provide a uniform cell product with stable characteristics for therapeutic or advanced research applications. We used cells collected at differentiation day 21, which are expected to have matured beyond the fetal stage. However, several of the assays we performed regarding calcium handling, cytoplasmic membrane potential and mitochondrial respiratory function indicate that at least a proportion of our iPS-CM population, although produced and purified using a highly standardized protocol, are more immature. Calcium transients of the iPS-CMs resemble calcium transients observed in primary neonatal mouse CMs  or mouse embryonic stem cell-derived cardiomyocytes (ESC-CMs) . However, compared with primary adult mouse CMs [36,37], calcium transients of iPS-CMs had reduced systolic maximal calcium as well as rates of both fluorescence rise during systole and decay during diastole. Electrophysiological data indicate that iPS-CMs display properties as described previously for fetal CMs and ESC-CMs [10,38,39] and the Seahorse data suggest that iPS-CMs exhibit an active metabolic profile that is comparable to that reported for human iPS-CMs  and murine N-CMs [41-43]. Nevertheless, the comparison with N-CMs appears justified to us, since many functional and morphologic similarities have been previously reported and were also confirmed in our study. In the end, individual CMs developing in an artificial in vitro setting may display differing degrees of maturity, so that uniformity would be reached only when all cells have completely matured. Of note, Boheler and colleagues recently showed that the viability of ESC-CMs obtained at differentiation day 10 decreased as late as after 48 hours exposure to 0.5% O2 and serum and glucose deprivation . At that point, more than 70% of the immature ESC-CMs were still viable, while late-stage ESC-CMs obtained on differentiation day 18 were much more sensitive to “simulated ischemia”. It has been well documented that CMs isolated from fetal hearts are less sensitive to hypoxia/ischemia than those from neonatal hearts . Comparison with mature/adult CMs is problematic because naïve adult CMs are difficult to culture, but intact neonatal hearts have been shown to be more sensitive to ischemia than mature hearts . Nevertheless, our data allow us to conclude that murine iPS-CMs created with this well-established protocol, which has been used in numerous experimental settings [14,46,47], have a distinct deficit regarding their tolerance to “simulated ischemia” that needs to be taken into account when interpreting outcome data and requires countering measures.
One such measure may be the preceding or concomitant incubation with MSCs or, as in our experiments, with MSC-CoM. We have shown previously that MSC-CoM increases the hypoxia/GSD tolerance of the CM-like HL-1 cells , and other groups demonstrated the efficacy of this approach in intact ischemic hearts [49,50]. MSC-CoM increased the cellular redox activity in iPS-CMs subjected to hypoxia/GSD approximately 1.3-fold, a modest but possibly relevant improvement which might be further enhanced by concentrating the medium or adding live MSCs . FB-CoM did only partially mimic the cytoprotective effects of MSC-CoM, which emphasizes the ‘beneficial’ specificity of MSC-released paracrine factors. On the molecular level, our model did not induce mRNA expression of hypoxia-inducible genes such as Hif1α, Vegf and Glut-1, but Hsp70 transcription was upregulated and further augmented in the presence of MSC-CoM. This is in line with other studies showing that heat shock proteins support the survival of cells exposed to environmental stress [51-53], as well as with reports showing that HSP70 promotes CM survival by inhibiting pro-apoptotic pathways that include caspase- and Fas-mediated death cascades . Furthermore, Bcl-2, Bcl-xL and Bad transcripts were reduced in hypoxia while the Bax/Bcl-2 and Bad/Bcl-xL ratio in hypoxia increased, which agrees with the increased caspase activity that we detected. Regarding the canonical kinase signaling pathways, MSC-CoM in our study prevented reduction in PKCε protein levels and restored STAT3 phosphorylation to almost basal levels, confirming the activation of cell survival pathways by paracrine factors that were also shown to mediate the MSC-CoM response in other myocyte cell types .
The simulated ischemia model we used in these in vitro experiments is clearly only a rudimentary representation of the situation present in an ischemic heart. Moreover, we concentrated on the damage induced by “simulated ischemia” alone but did not perform experiments that mimic reperfusion/reoxygenation injury. Also, our iPS-CM population was genetically modified and purified by antibiotic selection, while the N-CMs we used were naïve cells. While N-CM purity was originally confirmed to be high, it cannot be ruled out that during longer cultivation periods the proportion of proliferative non-CM cells increased.
In summary, we demonstrated that 3 hours hypoxia and GSD provoke cell stress and damage in iPS-CMs that exceeds that of naïve N-CMs, although the iPS-CMs we used showed several aspects of less mature CMs, which are considered to be more resistant to hypoxia and/or ischemia. While the reasons for this increased susceptibility are not entirely clear, a translationally practical approach to influence it may be the concomitant treatment with MSC-CoM via HSP70 expression, preservation of PKCε-dependent signaling cascades and further activation of STAT3-dependent signaling cascades. Ultimately, this strategy may help improve the efficacy of regenerative therapies involving CMs derived from iPS cells.
This article is part of a thematic series on Cardiovascular regeneration edited by Ronald Li. Other articles in the series can be found online at http://stemcellres.com/series/cardiovascular.
action potential duration at 90% of repolarization
bovine serum albumin
Dulbecco’s modified Eagle's Medium
embryonic stem cell-derived cardiomyocyte
fetal bovine serum
green fluorescent protein
Hank’s balanced salts modified buffer
high content screening
Iscove’s modified Dulbecco’s medium
induced pluripotent stem cell
induced pluripotent stem cell-derived cardiomyocyte
mesenchymal stromal cell
mesenchymal stromal cell-conditioned medium
oxygen consumption rate
reactive oxygen species
tetramethylrhodamine methyl ester
The authors thank Rebecca Dieterich and Maike Kreutzenbeck for technical assistance. This work was supported by a grant from the German Ministry for Education and Research (BMBF) to CS (grant no. 01GN0948), TŠ, YHC and JH (grant no. 01GN0947) and Köln Fortune Program to TŠ.
- Wang WE, Chen X, Houser SR, Zeng C. Potential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart disease. Clin Sci (Lond). 2013;125:319–27.View ArticlePubMed CentralPubMedGoogle Scholar
- Zwi-Dantsis L, Gepstein L. Induced pluripotent stem cells for cardiac repair. Cell Mol Life Sci. 2012;69:3285–99.View ArticlePubMedGoogle Scholar
- Lian X, Zhang J, Azarin SM, Zhu K, Hazeltine LB, Bao X, et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nat Protoc. 2013;8:162–75.View ArticlePubMed CentralPubMedGoogle Scholar
- Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan X, Peters A, et al. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One. 2011;6:e18293.View ArticlePubMed CentralPubMedGoogle Scholar
- Don CW, Murry CE. Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts. J Cell Mol Med. 2013;17:1355–62.View ArticlePubMed CentralPubMedGoogle Scholar
- Hou D, Youssef EA, Brinton TJ, Zhang P, Rogers P, Price ET, et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation. 2005;112:I150–6.PubMedGoogle Scholar
- Boheler KR, Joodi RN, Qiao H, Juhasz O, Urick AL, Chuppa SL, et al. Embryonic stem cell-derived cardiomyocyte heterogeneity and the isolation of immature and committed cells for cardiac remodeling and regeneration. Stem Cells Int. 2011;2011:10.View ArticleGoogle Scholar
- Yu T, Miyagawa S, Miki K, Saito A, Fukushima S, Higuchi T, et al. In vivo differentiation of induced pluripotent stem cell-derived cardiomyocytes. Circ J. 2013;77:1297–306.View ArticlePubMedGoogle Scholar
- Keung W, Boheler K, Li R. Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther. 2014;5:17.View ArticlePubMed CentralPubMedGoogle Scholar
- Kuzmenkin A, Liang H, Xu G, Pfannkuche K, Eichhorn H, Fatima A, et al. Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. FASEB J. 2009;23:4168–80.View ArticlePubMedGoogle Scholar
- Kang PM, Haunstetter A, Aoki H, Usheva A, Izumo S. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res. 2000;87:118–25.View ArticlePubMedGoogle Scholar
- Sedmera D, Kucera P, Raddatz E. Developmental changes in cardiac recovery from anoxia-reoxygenation. Am J Physiol Regul Integr Comp Physiol. 2002;283:R379–88.View ArticlePubMedGoogle Scholar
- Min J-Y, Sullivan MF, Yang Y, Zhang J-P, Converso KL, Morgan JP, et al. Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs. Ann Thorac Surg. 2002;74:1568–75.View ArticlePubMedGoogle Scholar
- Rubach M, Adelmann R, Haustein M, Drey F, Pfannkuche K, Xiao B, et al. Mesenchymal stem cells and their conditioned medium improve integration of purified induced pluripotent stem cell-derived cardiomyocyte clusters into myocardial tissue. Stem Cells Dev. 2014;23:643–53.View ArticlePubMed CentralPubMedGoogle Scholar
- Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol. 2007;25:1177–81.View ArticlePubMedGoogle Scholar
- Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, Nygren JM, et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med. 2006;203:2315–27.View ArticlePubMed CentralPubMedGoogle Scholar
- Nguemo F, Fleischmann B, Kamanyi A. Duan, Huamin L, Malan D, et al. Murine embryonic stem cell differentiation into cardiomyocytes requires L-type Ca2+ channel activity. J Stem Cells Regen Med. 2007;2:105–6.PubMedGoogle Scholar
- Bialik S, Cryns VL, Drincic A, Miyata S, Wollowick AL, Srinivasan A, et al. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. Circ Res. 1999;85:403–14.View ArticlePubMedGoogle Scholar
- Drey F, Choi YH, Neef K, Ewert B, Tenbrock A, Treskes P, et al. Noninvasive in vivo tracking of mesenchymal stem cells and evaluation of cell therapeutic effects in a murine model using a clinical 3.0 T MRI. Cell Transplant. 2013;22:1971–80.View ArticlePubMedGoogle Scholar
- Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.View ArticlePubMed CentralPubMedGoogle Scholar
- Nasseri BA, Ebell W, Dandel M, Kukucka M, Gebker R, Doltra A, et al. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial. Eur Heart J. 2014;35:1263–74.View ArticlePubMedGoogle Scholar
- Martins-Taylor K, Xu R-H. Concise review: genomic stability of human induced pluripotent stem cells. Stem Cells. 2012;30:22–7.View ArticlePubMedGoogle Scholar
- Quinlan AR, Boland MJ, Leibowitz ML, Shumilina S, Pehrson SM, Baldwin KK, et al. Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming. Cell Stem Cell. 2011;9:366–73.View ArticlePubMed CentralPubMedGoogle Scholar
- Pfannkuche K, Liang H, Hannes T, Xi J, Fatima A, Nguemo F, et al. Cardiac myocytes derived from murine reprogrammed fibroblasts: intact hormonal regulation, cardiac ion channel expression and development of contractility. Cell Physiol Biochem. 2009;24:73–86.View ArticlePubMedGoogle Scholar
- Ng WA, Grupp IL, Subramaniam A, Robbins J. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res. 1991;68:1742–50.View ArticlePubMedGoogle Scholar
- Nikoletopoulou V, Markaki M, Palikaras K, Tavernarakis N. Crosstalk between apoptosis, necrosis and autophagy. Biochim Biophys Acta. 2013;1833:3448–59.View ArticlePubMedGoogle Scholar
- Chao W, Shen Y, Li L, Rosenzweig A. Importance of FADD signaling in serum deprivation- and hypoxia-induced cardiomyocyte apoptosis. J Biol Chem. 2002;277:31639–45.View ArticlePubMedGoogle Scholar
- Zhu W, Chen J, Cong X, Hu S, Chen X. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells. 2006;24:416–25.View ArticlePubMedGoogle Scholar
- Yin Q, Jin P, Liu X, Wei H, Lin X, Chi C, et al. SDF-1α inhibits hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells through PI3K/Akt and ERK1/2 signaling pathways. Mol Biol Rep. 2011;38:9–16.View ArticlePubMedGoogle Scholar
- Schamberger CJ, Gerner C, Cerni C. Caspase-9 plays a marginal role in serum starvation-induced apoptosis. Exp Cell Res. 2005;302:115–28.View ArticlePubMedGoogle Scholar
- Carlile GW, Smith DH, Wiedmann M. Caspase-3 has a nonapoptotic function in erythroid maturation. Blood. 2004;103:4310–6.View ArticlePubMedGoogle Scholar
- Khalil H, Peltzer N, Walicki J, Yang J-Y, Dubuis G, Gardiol N, et al. Caspase-3 protects stressed organs against cell death. Mol Cell Biol. 2012;32:4523–33.View ArticlePubMed CentralPubMedGoogle Scholar
- Solá S, Aranha M, Rodrigues CP. Driving apoptosis-relevant proteins toward neural differentiation. Mol Neurobiol. 2012;46:316–31.View ArticlePubMedGoogle Scholar
- Sellers ZM, De Arcangelis V, Xiang Y, Best PM. Cardiomyocytes with disrupted CFTR function require CaMKII and Ca2+-activated Cl− channel activity to maintain contraction rate. J Physiol. 2010;588:2417–29.View ArticlePubMed CentralPubMedGoogle Scholar
- Guo A, Yang HT. Ca2+ removal mechanisms in mouse embryonic stem cell-derived cardiomyocytes. Am J Physiol Cell Physiol. 2009;297:C732–41.View ArticlePubMedGoogle Scholar
- Nakayama H, Wilkin BJ, Bodi I, Molkentin JD. Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J. 2006;20:1660–70.View ArticlePubMed CentralPubMedGoogle Scholar
- Petzhold D, da Costa-Goncalves A, Gross V, Morano I. Spinophilin is required for normal morphology, Ca2+ homeostasis and contraction but dispensable for β-adrenergic stimulation of adult cardiomyocytes. J Muscle Res Cell Motil. 2011;32:243–8.View ArticlePubMedGoogle Scholar
- Maltsev VA, Wobus AM, Rohwedel J, Bader M, Hescheler J. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res. 1994;75:233–44.View ArticlePubMedGoogle Scholar
- Zhang Z, Xu Y, Song H, Rodriguez J, Tuteja D, Namkung Y, et al. Functional roles of Ca(v)1.3 (alpha(1D)) calcium channel in sinoatrial nodes: insight gained using gene-targeted null mutant mice. Circ Res. 2002;90:981–7.View ArticlePubMedGoogle Scholar
- Rana P, Anson B, Engle S, Will Y. Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening. Toxicol Sci. 2012;130:117–31.View ArticlePubMedGoogle Scholar
- Sansbury BE, Jones SP, Riggs DW, Darley-Usmar VM, Hill BG. Bioenergetic function in cardiovascular cells: the importance of the reserve capacity and its biological regulation. Chem Biol Interact. 2011;191:288–95.View ArticlePubMed CentralPubMedGoogle Scholar
- Guo S, Olm-Shipman A, Walters A, Urciuoli WR, Devito S, Nadtochiy SM, et al. A cell-based phenotypic assay to identify cardioprotective agents. Circ Res. 2012;110:948–57.View ArticlePubMed CentralPubMedGoogle Scholar
- Neary MT, Ng K-E, Ludtmann MHR, Hall AR, Piotrowska I, Ong S-B, et al. Hypoxia signaling controls postnatal changes in cardiac mitochondrial morphology and function. J Mol Cell Cardiol. 2014;74:340–52.View ArticlePubMed CentralPubMedGoogle Scholar
- Coles JG, Boscarino C, Takahashi M, Grant D, Chang A, Ritter J, et al. Cardioprotective stress response in the human fetal heart. J Thorac Cardiovasc Surg. 2005;129:1128–36.View ArticlePubMedGoogle Scholar
- Wittnich C, Peniston C, Ianuzzo D, Abel JG, Salerno TA. Relative vulnerability of neonatal and adult hearts to ischemic injury. Circulation. 1987;76:V156–60.PubMedGoogle Scholar
- Halbach M, Peinkofer G, Baumgartner S, Maass M, Wiedey M, Neef K, et al. Electrophysiological integration and action potential properties of transplanted cardiomyocytes derived from induced pluripotent stem cells. Cardiovasc Res. 2013;100:432–40.View ArticlePubMedGoogle Scholar
- Xi J, Khalil M, Shishechian N, Hannes T, Pfannkuche K, Liang H, et al. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells. FASEB J. 2010;24:2739–51.View ArticlePubMedGoogle Scholar
- Bader AM, Brodarac A, Klose K, Bieback K, Choi Y-H, Kurtz A, et al. Mechanisms of paracrine cardioprotection by cord blood mesenchymal stromal cells. Eur J Cardiothorac Surg. 2014;45:983–92.View ArticlePubMedGoogle Scholar
- Timmers L, Lim SK, Hoefer IE, Arslan F, Lai RC, van Oorschot AA, et al. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res. 2011;6:206–14.View ArticlePubMedGoogle Scholar
- Angoulvant D, Ivanes F, Ferrera R, Matthews PG, Nataf S, Ovize M. Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury. J Heart Lung Transplant. 2011;30:95–102.View ArticlePubMedGoogle Scholar
- Latchman DS. Heat shock proteins and cardiac protection. Cardiovasc Res. 2001;51:637–46.View ArticlePubMedGoogle Scholar
- Mayer MP, Bukau B. Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci. 2005;62:670–84.View ArticlePubMed CentralPubMedGoogle Scholar
- Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G. Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle. 2006;5:2592–601.View ArticlePubMedGoogle Scholar
- Zhao Y, Wang W, Qian L. Hsp70 may protect cardiomyocytes from stress-induced injury by inhibiting Fas-mediated apoptosis. Cell Stress Chaperones. 2007;12:83–95.View ArticlePubMed CentralPubMedGoogle Scholar
- Mowat FM, Luhmann UFO, Smith AJ, Lange C, Duran Y, Harten S, et al. HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia. PLoS One. 2010;5:e11103.View ArticlePubMed CentralPubMedGoogle Scholar
- Mizuno S, Bogaard HJ, Kraskauskas D, Alhussaini A, Gomez-Arroyo J, Voelkel NF, et al. p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice. Am J Physiol Lung Cell Mol Physiol. 2011;300:L753–61.View ArticlePubMedGoogle Scholar
- Asano T, Tanaka K-I, Yamakawa N, Adachi H, Sobue G, Goto H, et al. HSP70 confers protection against indomethacin-induced lesions of the small intestine. J Pharmacol Exp Ther. 2009;330:458–67.View ArticlePubMedGoogle Scholar
- Wen J, Ribeiro R, Zhang Y. Specific PKC isoforms regulate LPS-stimulated iNOS induction in murine microglial cells. J Neuroinflammation. 2011;8:38.View ArticlePubMed CentralPubMedGoogle Scholar
- Deng W, Wang D-A, Gosmanova E, Johnson LR, Tigyi G. LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway. Am J Physiol Gastrointest Liver Physiol. 2003;284:G821–9.View ArticlePubMedGoogle Scholar
- Medearis S, Han IC, Huang JK, Yang P, Jaffe GJ. The Role of Bcl-xL in mouse RPE cell survival. Invest Ophthalmol Vis Sci. 2011;52:6545–51.View ArticlePubMed CentralPubMedGoogle Scholar
- Fielhaber JA, Carroll SF, Dydensborg AB, Shourian M, Triantafillopoulos A, Harel S, et al. Inhibition of mammalian target of rapamycin augments lipopolysaccharide-induced lung injury and apoptosis. J Immunol. 2012;188:4535–42.View ArticlePubMedGoogle Scholar
- Chen T, Wang Q, Cui J, Yang W, Shi Q, Hua Z, et al. Induction of apoptosis in mouse liver by Microcystin-LR: a combined transcriptomic, proteomic, and simulation strategy. Mol Cell Proteomics. 2005;4:958–74.View ArticlePubMedGoogle Scholar
- Ellmers LJ, Scott NJA, Piuhola J, Maeda N, Smithies O, Frampton CM, et al. Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis. J Mol Endocrinol. 2007;38:245–57.View ArticlePubMedGoogle Scholar
- Zhou Y, Cheng G, Dieter L, Hjalt TA, Andrade FH, Stahl JS, et al. An altered phenotype in a conditional knockout of Pitx2 in extraocular muscle. Invest Ophthalmol Vis Sci. 2009;50:4531–41.View ArticlePubMed CentralPubMedGoogle Scholar
- Im J-E, Song S-H, Kim JY, Kim KL, Baek SH, Lee DR, et al. Vascular differentiation of multipotent spermatogonial stem cells derived from neonatal mouse testis. Exp Mol Med. 2012;44:303–9.View ArticlePubMed CentralPubMedGoogle Scholar
- Chen IY, Gheysens O, Ray S, Wang Q, Padmanabhan P, Paulmurugan R, et al. Indirect imaging of cardiac-specific transgene expression using a bidirectional two-step transcriptional amplification strategy. Gene Ther. 2010;17:827–38.View ArticlePubMed CentralPubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.